Virulence determinants and protective antigens of Francisella tularensis

被引:66
作者
Sjöstedt, A [1 ]
机构
[1] Umea Univ, Dept Clin Bacteriol, Umea, Sweden
关键词
D O I
10.1016/S1369-5274(03)00002-X
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Very little is known about virulence mechanisms of the highly virulent bacterium Francisella tularensis. Specific genetic features of F. tularensis have been obstacles for the development of effective tools for genetic manipulation. However, recent genomic sequencing and large-scale proteomic work have resulted in a substantial increase in the knowledge of F. tularensis. There is also a paucity of information on potential vaccine candidates. Recent work assessing the protective efficacy of the F. tularensis lipopolysaccharide has resulted in important contributions to the understanding of host-protective mechanisms. T-cell-mediated immunity appears to be crucial to protect against virulent F. tularensis strains. Few other vaccine candidates have been identified.
引用
收藏
页码:66 / 71
页数:6
相关论文
共 49 条
[1]   Inability of the Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins [J].
Ancuta, P ;
Pedron, T ;
Girard, R ;
Sandstrom, G ;
Chaby, R .
INFECTION AND IMMUNITY, 1996, 64 (06) :2041-2046
[2]   GROWTH OF FRANCISELLA-SPP IN RODENT MACROPHAGES [J].
ANTHONY, LSD ;
BURKE, RD ;
NANO, FE .
INFECTION AND IMMUNITY, 1991, 59 (09) :3291-3296
[3]  
Baron GS, 1999, FEMS MICROBIOL LETT, V176, P85, DOI 10.1111/j.1574-6968.1999.tb13646.x
[4]   MgIA and MgIB are required for the intramacrophage growth of Francisella novicida [J].
Baron, GS ;
Nano, FE .
MOLECULAR MICROBIOLOGY, 1998, 29 (01) :247-259
[5]   IMMUNIZATION AGAINST TULAREMIA - ANALYSIS OF EFFECTIVENESS OF LIVE FRANCISELLA-TULARENSIS VACCINE IN PREVENTION OF LABORATORY-ACQUIRED TULAREMIA [J].
BURKE, DS .
JOURNAL OF INFECTIOUS DISEASES, 1977, 135 (01) :55-60
[7]   Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen [J].
Conlan, JW ;
Shen, H ;
Webb, A ;
Perry, MB .
VACCINE, 2002, 20 (29-30) :3465-3471
[8]  
CONLAN JW, 2003, IN PRESS MICROB PATH
[9]  
COUNCILMAN WT, 1921, T ASSOC AM PHYSICIAN, V36, P135
[10]   Isolation and characterization of Francisella novicida mutants defective in lipopolysaccharide biosynthesis [J].
Cowley, SC ;
Gray, CJ ;
Nano, FE .
FEMS MICROBIOLOGY LETTERS, 2000, 182 (01) :63-67